The guidelines aim to “provide greater clarity on how to scientifically validate the reprocessing instructions that are part of device labeling,” according to the FDA. The guidelines are targeted toward device manufacturers.
The FDA will host a public workshop to seek input from stakeholders, including healthcare providers, on June 8-9, 2011.
Read the FDA release on reusable medical devices.
Related Articles on Medical Devices and Supplies:
B Braun Receives Permanent Injunction in Patent Infringement Case
Expiring Patents May Produce Up to 90% Savings on Drugs
Integra Signs 3 Year Contract With Novation for Surgical Headlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.